Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has earned an average rating of “Hold” from the eighteen research firms that are covering the firm, MarketBeat reports. Eleven investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $11.26.

TDOC has been the topic of a number of research analyst reports. The Goldman Sachs Group dropped their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America increased their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Royal Bank of Canada boosted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Oppenheimer lowered their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th.

Teladoc Health Stock Up 5.3 %

Teladoc Health stock opened at $8.86 on Tuesday. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.53 and a beta of 1.27. The company’s 50 day simple moving average is $10.40 and its 200 day simple moving average is $9.77. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $15.43.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Hedge funds have recently added to or reduced their stakes in the business. Versant Capital Management Inc increased its holdings in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC bought a new position in Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after acquiring an additional 1,612 shares during the last quarter. Sterling Capital Management LLC grew its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in shares of Teladoc Health during the fourth quarter worth approximately $60,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.